WallStSmart
IMDX

Insight Molecular Diagnostics Inc.

NASDAQ: IMDX · HEALTHCARE · DIAGNOSTICS & RESEARCH

$3.83
-8.81% today

Updated 2026-04-29

Market cap
$123.53M
P/E ratio
P/S ratio
30.46x
EPS (TTM)
$-1.65
Dividend yield
52W range
$2 – $9
Volume
0.3M

Insight Molecular Diagnostics Inc. (IMDX) Financial statements

SEC filings — annual and quarterly data.

Income statement — annual

Item2013201420152016201720182019202020212022202320242025
Revenue$1.22M$2.20M$958000.00$1.50M$1.88M$4.05M
Revenue growth (YoY)+80.8%-56.4%+56.9%+25.1%+115.6%
Cost of revenue$283000.00$387000.00$580000.00$559000.00$344000.00$1.85M$778000.00$976000.00$1.09M$1.14M$3.87M
Gross profit$-283000.00$-387000.00$-580000.00$-559000.00$-344000.00$-639000.00$1.42M$-18000.00$413000.00$740000.00$190000.00
Gross margin-52.5%64.6%-1.9%27.5%39.3%4.7%
R&D$2.94M$3.96M$4.53M$5.68M$7.17M$6.51M$6.79M$9.80M$5.04M$7.30M$9.29M$9.84M$15.90M
SG&A$552000.00$1.01M$4.19M$5.46M$9.23M$7.01M$13.28M$16.79M$20.39M$21.52M$12.98M$13.14M$10.63M
Operating income$-3.50M$-4.97M$-8.72M$-11.14M$-18.85M$-15.20M$-22.24M$-29.71M$-53.73M$-18.00M$-25.14M$-61.04M$-30.58M
Operating margin-2443.3%-2444.3%-1878.6%-1672.4%-3245.1%-754.1%
EBITDA$-3.22M$-4.69M$-8.44M$-11.14M$-18.27M$-15.20M$-21.89M$-30.54M$-48.46M$-13.31M$-23.12M$-59.02M$-28.38M
EBITDA margin-2511.5%-2204.6%-1389.2%-1538.5%-3137.4%-699.9%
EBIT$-3.50M$-4.97M$-8.72M$-11.53M$-18.85M$-15.76M$-22.24M$-30.93M$-52.66M$-18.53M$-24.80M$-60.58M$-30.58M
Interest expense$2000.00$19000.00$28000.00$217000.00$216000.00$299000.00$252000.00$209000.00$83000.00$52000.00$84000.00$109000.00
Income tax
Effective tax rate0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%
Net income$-3.50M$-4.99M$-8.73M$-11.17M$-19.38M$-15.75M$-22.33M$-29.93M$-64.10M$-72.90M$-27.78M$-60.66M$-50.22M
Net income growth (YoY)-42.7%-75.2%-27.9%-73.5%+18.7%-41.7%-34.0%-114.1%-13.7%+61.9%-118.4%+17.2%
Profit margin-2461.5%-2916.2%-7609.8%-1848.4%-3225.0%-1238.5%